Introduction: What is Timothy syndrome? 

Timothy Syndrome (TS) is an extremely rare genetic disorder caused by a mutation in the CACNA1C gene.¹ This disease affects multiple organ systems, including the circulatory, muscular and nervous systems, which can cause life-threatening symptoms, leading to sudden death.¹ Due to the severity of the condition, most patients have a short lifespan.² Therefore, developing diagnostic tools and treatment strategies is crucial to improving the quality of life and survival of individuals with TS. One promising approach being explored is gene therapy. 

Unravelling the mystery of genes: How tiny mistakes lead to genetic disorders 

Genetic disorders are diseases caused by mutations in the genes, but what does that mean and how does it impact our health?³

What are DNA and genes? 

DNA serves as the master blueprint of the cell, storing instructions in the form of base sequences (A, T, G and C), that is required to create everything within the cell.⁴ These instructions are safely housed in the nucleus of the cell.⁴

Genes are the genetic code of the DNA that help guide our cells to produce proteins required for our cells to function.⁴ For example, there are genes that code for antibodies, which are important proteins that the immune cells produce during an immune response to fight against infections. Without these genes, we would be unable to defend ourselves against pathogens. 

How do cells produce proteins in the cytoplasm from genes? 

If DNA is safely locked away in the nucleus while the ribosomes (the cell's protein builders) float in the gel-like cytoplasm, how do they access the instructions to make proteins? The answer is that a small, temporary copy of the necessary genetic information, called mRNA, is created to deliver the blueprint for protein production.⁵

Figure 1. Highlighting the different structures of a cell. (Created by Gobika Kugan with BioRender)

Genes are more complex than they seem. They consist of two different components known as exons and introns.⁵ Exons contain the actual instructions for making proteins, while introns, acting as non-coding fillers, are interspersed between them.⁵ When mRNA is first created, the introns have to be removed before reaching the ribosomes in a process known as splicing.⁵ Interestingly, exons can also be rearranged through a process called alternative splicing, allowing a single gene to produce multiple types of proteins, known as isoforms.⁵

Figure 2. shows an example of how splicing works. The introns are removed from the pre-mRNA, which can form different mRNAs through the varying arrangements of exons. (Created by Gobika Kugan with BioRender)

Genes vs mutations

Mutations are random errors that alter the gene sequence, i.e the instructions.⁶ These changes can happen in several ways:⁶ 

• Substitution- A single base in the gene is replaced with a different base
• Deletion- A base is removed from the gene sequence
• Insertion- An additional base is inserted into the gene sequence

Since proteins play crucial roles in various cellular processes, these mutations can disrupt their function, potentially affecting the cell, tissue, or even entire organ systems.⁶

Gene therapy aims to treat genetic disorders by directly targeting and correcting the DNA mutations at their source, effectively addressing the root cause of the condition.⁷

Understanding the genetic mutation behind TS

What is the genetic mutation? 

TS was first identified in 2004 and is named after Katherine W. Timothy, who played a key role in discovering the mutation responsible for the condition.⁸ The gain-of-function mutation occurs in the CACNA1C gene, which causes an increased activity of the Cav1.2 calcium channel protein.^9,10

Why are calcium channels so important? 

Calcium channels are found in the membrane of cells throughout the body, where they play vital roles in tissues such as the heart, muscles, and nerves.¹¹ They rapidly transport calcium ions across the cell or organelle (e.g. mitochondria) membrane, ensuring efficient signalling and cellular function.¹¹ 

The Cav1.2 calcium channel proteins are typically highly abundant in the heart tissue, facilitating the movement of calcium ions that trigger muscle contractions.¹⁰ An excessive increase in these proteins can cause rapid and irregular heartbeats, leading to conditions such as long QT syndrome.¹⁰

Cav1.2 is also highly abundant in the hippocampus, a brain region essential for forming spatial and fear memory, and regulating emotional behaviours.¹² These calcium channels play a crucial role in transmitting signals between nerves through the movement of calcium ions.¹³ An increased activity of Cav1.2 in the brain, has been linked to neurological conditions such as autism and schizophrenia.^14,15

Why are there two types of TS? 

Even though TS is caused by a mutation in a single gene, different forms of the disorder exist. This is because the mutations are occurring in either exon 8 or exon 8a of the CACNA1C gene. Since different exons are affected, the resulting changes to the calcium channel isoforms can lead to differing effects.⁹ As a result, the severity and clinical presentation of TS can vary depending on the mutation.⁹

 Table 1. Showing the different clinical presentations of TS Type 1 and Type 2.^9,1

The promise of gene therapy for TS 

The current treatment of TS primarily focuses on monitoring and managing symptoms. An example includes the use of beta-blockers or verapamil, which help regulate long QT syndrome by lowering blood pressure.¹ Given the current treatment options, gene therapy is considered a more promising approach for individuals with TS, as it modifies genes to achieve a therapeutic effect. 

How does gene therapy work? 

The method of gene therapy can be classified as either in vivo or ex vivo.⁷ In vivo gene therapy involves delivering the therapeutic gene directly into the body, whilst ex vivo therapy involves extracting cells, modifying them outside the body, and then reinserting them.⁷ 

The question is, how is the delivery and the editing of the DNA achieved? Well, various technologies have been developed for gene therapy by correcting, disrupting, or replacing faulty genes.¹⁶ The different technologies that can be used in gene therapy include recombinant DNA technology and CRISPR-Cas9.¹⁷ 

Recombinant DNA technology

It is first important to understand why we use viral vectors in gene editing. Viruses infect cells by inserting their DNA (i.e. the viral plasmid) into the host’s DNA, which allows them to multiply. This will eventually kill the cell and cause the symptoms we experience. Scientists have found a way to use this ability in a technique known as recombinant DNA technology.¹⁸ 

In recombinant DNA technology, the viral plasmid is edited through the use of restriction enzymes. These enzymes can modify the vector by making cuts in the DNA, allowing the desired therapeutic gene to be inserted.¹⁸ The faulty cell will then be exposed to viruses containing the modified vector, allowing the integration of the desired gene.¹⁸ This enables us to correct genetic defects in many individuals with genetic disorders.⁷

CRISPR-Cas9 

CRISPR-Cas9 is a different type of gene-editing technology that can cut at any base we want. This is because it uses a Cas9 enzyme to cut the DNA at specific bases by pairing up with a molecule that helps direct it, known as the guide RNA.¹⁶ Researchers can modify the CRISPR-Cas9 technology to target specific sequences, including mutations. This approach is particularly useful for gene disruption, as cutting at a mutation can prevent its expression, potentially correcting disease-causing genetic errors.¹⁶ 

Many gene therapies remain in the research phase, but there is hope as some recombinant DNA technologies and CRISPR-Cas9-based therapies have already demonstrated success and are now being used in medical treatments.

Future potential gene therapy for TS 

A promising gene therapy approach for TS involves the use of antisense oligonucleotides (ASOs). ASOs are short, synthetic molecules that can bind to pre-mRNA to inhibit splicing or to mRNA to promote its degradation, which helps prevent the production of specific proteins.¹⁹ 

A recent study tested various ASOs and identified ones that can target the CACNA1C gene. ​​The lead ASO effectively reduced the activity of exon 8A without lowering the overall levels of Cav1.2 proteins.¹⁹ While this approach shows potential, further research is needed to address limitations, such as improving the specificity of ASOs.¹⁹ 

Challenges in developing gene therapy for TS

Although gene therapy offers a targeted therapeutic solution, several challenges would need to be considered for its widespread implementation in healthcare. These include efficacy concerns, safety risks, variability in outcomes and high costs. 

1. One major concern is the potential for viral vectors to trigger immune responses, as treated cells can produce viral particles. This immune activation can reduce the therapy’s effectiveness by destroying modified cells²⁰
2. Triggering immune responses can be dangerous as it can lead to toxicities, such as inflammation of the liver, which has been observed in treatments using adeno-associated viral vectors.²¹ 
3. Liver toxicity has also been observed in gene therapy when the therapeutic gene is unintentionally delivered to the liver, causing unwanted effects that can be especially harmful to patients with pre-existing liver disease²²
4. Gene therapy requires further optimisation to ensure consistent and reliable results, as the success of gene modification can vary between patients²³ 
5. The high cost of gene therapies remains a significant barrier, posing a challenge for the NHS in making these treatments accessible²³ 

Where to find support? 

Diseases like TS can have an emotional impact on families as they try their best to provide love, care and support to their children. If you are feeling overwhelmed, know that it is okay, and you are not alone as there are resources available to help. The TS Alliance offers confidential support, including up to eight free online counselling sessions. If you feel you could benefit from this, reach out through their contact form. 

Summary

Timothy Syndrome is a rare genetic disorder caused by mutations in the CACNA1C gene, which affects the Cav1.2 calcium channel function. This leads to severe symptoms, including heart abnormalities, developmental delays, and neurological issues. Given the complexity of the condition, current treatments focus on managing symptoms rather than addressing the underlying genetic cause. Gene therapies, such as antisense oligonucleotides, present a promising future approach by potentially correcting the faulty gene at its source. While still in the early research stages, advancements in gene-editing technologies offer hope for more effective and targeted treatments, improving both quality of life and survival rates for individuals with TS.